财报披露
依特钠(AEZS)03-28 22:35
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011637 Act: 34 Size: 91 KB 网页链接
简介:Aeterna Zentaris, Inc.于1990年9月12日 ,在Canada Business Corporations Act名下成立,并继续受其管理。Aeterna Zentaris是一家晚期药物的开发公司,专业从事肿瘤学和内分泌治疗。公司产品线包括从开发到销售所有阶段的化合物。公司的主要业务战略是与战略合作伙伴共同进步,其产品开发线上的重点候选产品主要用于肿瘤学和内分泌学领域。此外,该公司还继续推进其他临床和临床前程序,其中一些通过了不同政府机构的授权。公司的愿景是成为一个综合的专业生物制药公司。
今开:1.95 | 昨收:1.98 |
最高:1.96 | 最低:1.95 |
涨停价: | 跌停价: |
总市值:9501007 |
依特钠(AEZS)03-28 22:35
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011637 Act: 34 Size: 91 KB 网页链接
依特钠(AEZS)03-27 20:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011399 Act: 34 Size: 87 KB 网页链接
依特钠(AEZS)03-27 20:15
$依特钠(AEZS)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-011401 Act: 34 Size: 34 MB 网页链接
依特钠(AEZS)03-27 20:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011400 Act: 34 Size: 1 MB 网页链接
依特钠(AEZS)03-13 18:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-009703 Act: 34 Size: 142 KB 网页链接
依特钠(AEZS)02-27 19:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007860 Act: 34 Size: 213 KB 网页链接
依特钠(AEZS)02-27 19:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007859 Act: 34 Size: 97 KB 网页链接
依特钠(AEZS)02-15 22:45
$依特钠(AEZS)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-006824 Act: 34 Size: 14 MB 网页链接
依特钠(AEZS)02-20 19:05
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007057 Act: 34 Size: 181 MB 网页链接
依特钠(AEZS)02-16 06:05
$依特钠(AEZS)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001493152-24-006882 Act: 33 Size: 6 MB 网页链接
人类高蛋白质男士2021-10-01 22:11
$依特钠(AEZS)$ 搞个口服 什么的都就🔥爆了查看全文
冷枪手假亦真2021-10-01 21:52
$依特钠(AEZS)$ 不要停查看全文
冷枪手假亦真2021-10-01 02:50
$依特钠(AEZS)$ 低调加一点仓位查看全文
冷枪手假亦真2021-10-01 02:37
$依特钠(AEZS)$ 买点试试查看全文
冷枪手假亦真2021-07-27 23:46
$依特钠(AEZS)$ 底部反弹~买点查看全文
皮皮虾皮2021-06-11 02:00
$依特钠(AEZS)$ eyes on. Algo in play. Will buy if going down, will pass if going up.查看全文
富贵险中求簪的爸爸2021-04-22 02:24
$依特钠(AEZS)$ 毛票再来一轮查看全文
神鹰20072021-03-29 23:59
$依特钠(AEZS)$ dip buy IMO[跪了][跪了]查看全文
JJ-King8882021-03-29 21:51
$依特钠(AEZS)$ 跑步进场🏃🏃♀️🏃🏃♀️🏃查看全文
神鹰20072021-03-27 03:45
$依特钠(AEZS)$ still holding all my shares,let see who can be winner in the future 🙏🏻🙏🏻查看全文
北京时间2024年02月01日22时30分,依特钠(AEZS.us)股票出现异动,股价急速下挫5.88%。截至发稿,该股报1.76美元/股,成交量2股,换手率0.00%,振幅0.00%。 最近的财报数据显示,该股实现营业收入3000.00美... 网页链接
北京时间2023年12月27日00时35分,依特钠(AEZS.us)股票出现异动,股价快速跳水5.08%。截至发稿,该股报1.87美元/股,成交量4223股,换手率0.09%,振幅5.02%。 最近的财报数据显示,该股实现营业收入3000.00... 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011637 Act: 34 Size: 91 KB 网页链接
$依特钠(AEZS)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-011401 Act: 34 Size: 34 MB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011400 Act: 34 Size: 1 MB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-011399 Act: 34 Size: 87 KB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-009703 Act: 34 Size: 142 KB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007860 Act: 34 Size: 213 KB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007859 Act: 34 Size: 97 KB 网页链接
$依特钠(AEZS)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-007057 Act: 34 Size: 181 MB 网页链接
$依特钠(AEZS)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001493152-24-006882 Act: 33 Size: 6 MB 网页链接
$依特钠(AEZS)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001493152-24-006824 Act: 34 Size: 14 MB 网页链接